Pyridine-3-Sulfonyl Chloride CAS 16133-25-8 Puritas ≥98.5% (GC) Vonoprazan Fumarat Intermedia Factory
Supple Vonoprazan Fumarate ac Related medium
5-(2-Fluorophenyl) pyrrole-3-Carboxaldehyde CAS 881674-56-2
Pyridine-3-Sulfony Chloride CAS 16133-25-8
Vonoprazan Fumarate (TAK-438) CAS 1260141-27-2 881681-01-2
Nomen chemicum | Pyridine-3-Sulfony Chloride |
Synonyma | 3-Pyridinesulfonyl Chloride;3-Pyridylsulfonyl Chloride;m-Pyridinesulfonyl Chloride;Piperidine-3-Sulfonylchloride |
CAS Number | 16133-25-8 |
CATTUS Number | RF-PI540 |
Stock Status | In Stock, Productio Ascendite ad Tons |
Formulae hypotheticae | C5H4ClNO2S |
M. Pondus | 177.61 |
Brand | Ruifu Chemical |
Item | Specifications |
Aspectus | Hyalina vel pallide Yellow Liquid |
Puritas / Analysis Methodus | ≥98.5% (GC) |
Ferveret | 110.0~112.0℃/2mm Hg |
una immunditia | ≤0.50% |
Totalis immunditias | ≤1.5% |
Test Standard | Enterprise Standard |
Consuetudinem | Intermedium Vonoprazan Fumarate (CAS: 1260141-27-2) |
sarcina: Utrem, 25kg/ferrum, vel secundum exigentiam emptoris.
Repono Condition:Repone in vasis signatis in loco frigido et sicco;A luce et humore protege.
![1](https://a395.goodao.net/uploads/15.jpg)
![](https://a395.goodao.net/uploads/23.jpg)
Pyridine-3-Sulfony Chloride (CAS: 16133-25-8) medium est Vonoprazan Fumarate (CAS: 1260141-27-2).Vonoprazan Fumarate, ab Takeda et Otsuka inventa et evoluta, ab PMDA Iaponiae mense Decembri 2014 probata est, et curatione ulceris gastrici, ulceris duodeni et reflux esophagitis indicatur.Vonoprazan fumaratus novam mechanismum actionis quae acidum potassium-competitivum obstructores habet, quae certatim ligamen potassii ad H+, K+-ATPase (etiam proton sentinae notae) in ultimo gradu acidi gastrici secretionis in cellulis parietalibus gastrici prohibent.Vonoprazan non inhibet Na+, K+-ATPase activitatem etiam in concentionibus 500 vicibus altioribus quam valorum suorum IC50 contra gastricam H+, K+-ATPase actionem.Praeterea medicamentum a secretoriis gastrici statu non caret, dissimili PPIs.